Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura — Stella

Home/Thrombotic Thrombocytopenic Purpura, Acquired/

View on ClinicalTrials.gov

Recruiting

Back to Thrombotic Thrombocytopenic Purpura, Acquired trials

Trial locations(1 site)

Italy

Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan

Key details

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Enrollment target

~40 participants

Started

October 2025

Primary completion

June 2026

Age range

18 Years – 99 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.